Raia Drogasil S.A. (OTCMKTS:RADLY - Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $4.36, but opened at $4.5882. Raia Drogasil shares last traded at $4.5882, with a volume of 5,179 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded Raia Drogasil to a "hold" rating in a report on Thursday, April 9th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of "Hold".
Check Out Our Latest Stock Analysis on RADLY
Raia Drogasil Stock Up 0.4%
The company has a fifty day moving average price of $4.69 and a two-hundred day moving average price of $4.46.
Raia Drogasil Company Profile
(
Get Free Report)
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Raia Drogasil, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Raia Drogasil wasn't on the list.
While Raia Drogasil currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
